Drug Delivery Through Placenta and Then Breastmilk for Fetal Cystic Fibrosis: Collateral Benefit and Social Good Do Not Make an Acceptable Risk: Benefit Ratio

Gianna Morales co-authors study on ethical risks of fetal cystic fibrosis drug delivery via placenta and breastmilk, examining risk-benefit limits.